Trade Altimmune, Inc. - ALT CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.07 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023401% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001179% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 4.37 |
| Open | 4.41 |
| 1-Year Change | -41.36% |
| Day's Range | 4.34 - 4.56 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 17, 2025 | 4.51 | 0.19 | 4.40% | 4.32 | 4.59 | 4.31 |
| Apr 16, 2025 | 4.37 | -0.01 | -0.23% | 4.38 | 4.48 | 4.29 |
| Apr 15, 2025 | 4.50 | -0.02 | -0.44% | 4.52 | 4.67 | 4.39 |
| Apr 14, 2025 | 4.58 | -0.08 | -1.72% | 4.66 | 4.71 | 4.40 |
| Apr 11, 2025 | 4.36 | 0.28 | 6.86% | 4.08 | 4.38 | 4.07 |
| Apr 10, 2025 | 4.12 | 0.00 | 0.00% | 4.12 | 4.24 | 3.89 |
| Apr 9, 2025 | 4.17 | 0.60 | 16.81% | 3.57 | 4.43 | 3.55 |
| Apr 8, 2025 | 3.64 | -0.44 | -10.78% | 4.08 | 4.17 | 3.52 |
| Apr 7, 2025 | 3.95 | 0.00 | 0.00% | 3.95 | 4.18 | 3.70 |
| Apr 4, 2025 | 4.19 | -0.03 | -0.71% | 4.22 | 4.41 | 4.09 |
| Apr 3, 2025 | 4.43 | -0.02 | -0.45% | 4.45 | 4.70 | 4.39 |
| Apr 2, 2025 | 4.73 | 0.13 | 2.83% | 4.60 | 4.92 | 4.60 |
| Apr 1, 2025 | 4.71 | -0.17 | -3.48% | 4.88 | 5.10 | 4.67 |
| Mar 31, 2025 | 4.96 | -0.08 | -1.59% | 5.04 | 5.08 | 4.75 |
| Mar 28, 2025 | 5.28 | -0.20 | -3.65% | 5.48 | 5.51 | 5.27 |
| Mar 27, 2025 | 5.53 | 0.04 | 0.73% | 5.49 | 5.60 | 5.42 |
| Mar 26, 2025 | 5.54 | -0.22 | -3.82% | 5.76 | 5.81 | 5.53 |
| Mar 25, 2025 | 5.85 | -0.09 | -1.52% | 5.94 | 5.98 | 5.81 |
| Mar 24, 2025 | 6.01 | 0.18 | 3.09% | 5.83 | 6.13 | 5.77 |
| Mar 21, 2025 | 5.76 | 0.19 | 3.41% | 5.57 | 5.83 | 5.57 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Altimmune, Inc. Company profile
Altimmune, Inc., a clinical stage biopharmaceutical company, focused developing treatments for liver disease, immune modulating therapies, and vaccines. The company develops HepTcell, an immunotherapeutic product candidate that has completed Phase I clinical trial for patients chronically infected with the hepatitis B virus; NasoShield, an anthrax vaccine to provide for protection after a single intranasal administration; NasoVAX, a recombinant intranasal vaccine product candidate; and AdCOVID, a single-dose intranasal vaccine to protect against COVID-19 Its preclinical stage products include ALT-801, a novel peptide-based dual GLP-1/Glucagon receptor agonist for the treatment of non-alcoholic steatohepatitis; and ALT-702, an investigational tumor immunostimulant for treating cancer. The company also develops veterinary product candidates. It has a collaboration with the University of Alabama at Birmingham for the development of AdCOVID. Altimmune, Inc. is headquartered in Gaithersburg, Maryland.| Industry: | Bio Therapeutic Drugs |
910 Clopper Rd Ste 201S
GAITHERSBURG
MARYLAND 20878-1361
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com